Log in to save to my catalogue

Disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023...

Disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8a85e51d09b244bc90acbc2d5b365a34

Disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023 criteria

About this item

Full title

Disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023 criteria

Publisher

London: Nature Publishing Group UK

Journal title

Communications medicine, 2024-10, Vol.4 (1), p.219-11, Article 219

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Introduction
The 2023 nomenclature defined criteria for steatotic liver disease (SLD), including metabolic dysfunction-associated SLD (MASLD), alcohol-associated liver disease (ALD), and the overlapping MASLD/ALD (MetALD). We aimed to assess racial and ethnic disparities in the SLD prevalence among United States (US) adults based on this new nom...

Alternative Titles

Full title

Disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023 criteria

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8a85e51d09b244bc90acbc2d5b365a34

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8a85e51d09b244bc90acbc2d5b365a34

Other Identifiers

ISSN

2730-664X

E-ISSN

2730-664X

DOI

10.1038/s43856-024-00649-x

How to access this item